University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drugs
Nucleoside/Nucleotide Analogues
Nonnucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Chemokine Coreceptor Antagonists
Integrase Inhibitors
Pharmacokinetic Enhancers
Related Resources
About ARV Drugs
DHHS Guideline Tables
When to Start Treatment
Use with Caution
Advantages and Disadvantages: Initial Therapy
Not Recommended as Initial Therapy
Should Not Be Offered at Any Time
Adverse Events of ARVs
Dosage Adjustments for ARV-ARV Drug Interactions (Adult Dosing)
Interactions Database
Stanford Resistance Figures/Notes
Nucleoside/Nucleotide Analogues
Abacavir (Ziagen, ABC)
Didanosine (Videx, ddI)
Emtricitabine (Emtriva, FTC)
Lamivudine (Epivir, 3TC)
Stavudine (Zerit, d4T)
Tenofovir (Viread, TDF)
Zalcitabine (Hivid, ddC) Discontinued by manufacturer 12/31/06
Zidovudine (Retrovir, AZT, ZDV)
Nonnucleoside Reverse Transcriptase Inhibitors
Delavirdine (Rescriptor, DLV)
Efavirenz (Sustiva, Stocrin, EFV)
Etravirine (Intelence, TMC 125, ETV)
Nevirapine (Viramune, NVP)
Rilpivirine (Edurant, TMC 278, RPV)
Protease Inhibitors
Amprenavir (Agenerase, APV) Discontinued by manufacturer 10/07
Atazanavir (Reyataz, ATV)
Darunavir (Prezista, DRV, TMC 114)
Fosamprenavir (Lexiva, Telzir, FPV)
Indinavir (Crixivan, IDV)
Lopinavir/Ritonavir (Kaletra, LPV/r)
Nelfinavir (Viracept, NFV)
Ritonavir (Norvir, RTV)
Saquinavir (Invirase, SQV)
Tipranavir (Aptivus, TPV)
Fusion Inhibitors
Enfuvirtide (Fuzeon, ENF, T-20)
Chemokine Coreceptor Antagonists
Maraviroc (Selzentry, Celsentri, MVC)
Integrase Inhibitors
Elvitegravir (EVG)
Raltegravir (Isentress, RAL)
Dolutegravir (Tivicay, DTG)
Pharmacokinetic Enhancers
Cobicistat (GS-9530, COBI)